Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Needle injection trial aims to zap liver tumors without surgery

NCT ID NCT06689670

Summary

This study is testing whether a new injection called INT001 can safely destroy liver tumors in adults who cannot have surgery. Doctors will use imaging to guide a needle into the tumor and inject INT001, then check if the tumor is completely killed. Participants will receive the injection once and return for follow-up visits over 90 days to monitor their health and scan the treated area.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HCC - HEPATOCELLULAR CARCINOMA are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Koc University Hospital

    RECRUITING

    Topkapı, Istanbul, 34010, Turkey (Türkiye)

    Contact

    Contact Phone: •••-•••-•••• Email: •••••@•••••

Conditions

Explore the condition pages connected to this study.